183 related articles for article (PubMed ID: 11496020)
1. Fluoxetine in pathologic skin-picking: open-label and double-blind results.
Bloch MR; Elliott M; Thompson H; Koran LM
Psychosomatics; 2001; 42(4):314-9. PubMed ID: 11496020
[TBL] [Abstract][Full Text] [Related]
2. A double-blind trial of fluoxetine in pathologic skin picking.
Simeon D; Stein DJ; Gross S; Islam N; Schmeidler J; Hollander E
J Clin Psychiatry; 1997 Aug; 58(8):341-7. PubMed ID: 9515971
[TBL] [Abstract][Full Text] [Related]
3. Open-label escitalopram treatment for pathological skin picking.
Keuthen NJ; Jameson M; Loh R; Deckersbach T; Wilhelm S; Dougherty DD
Int Clin Psychopharmacol; 2007 Sep; 22(5):268-74. PubMed ID: 17690595
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine therapy in depersonalisation disorder: randomised controlled trial.
Simeon D; Guralnik O; Schmeidler J; Knutelska M
Br J Psychiatry; 2004 Jul; 185():31-6. PubMed ID: 15231553
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with Binge Eating Disorder.
Leombruni P; Pierò A; Lavagnino L; Brustolin A; Campisi S; Fassino S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1599-605. PubMed ID: 18598735
[TBL] [Abstract][Full Text] [Related]
6. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
[TBL] [Abstract][Full Text] [Related]
7. Psychogenic excoriation responding to fluoxetine: a case report.
Sharma H
J Indian Med Assoc; 2008 Apr; 106(4):245, 262. PubMed ID: 18828345
[TBL] [Abstract][Full Text] [Related]
8. Fluoxetine-Induced Skin Picking and Compulsive Behaviors in a Preschool Girl.
Çoşkun F; Bilgiç A
Clin Neuropharmacol; 2018; 41(5):192-193. PubMed ID: 30024442
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine for the treatment of fatigue in primary biliary cirrhosis: a randomized, double-blind controlled trial.
Talwalkar JA; Donlinger JJ; Gossard AA; Keach JC; Jorgensen RA; Petz JC; Lindor KD
Dig Dis Sci; 2006 Nov; 51(11):1985-91. PubMed ID: 17053955
[TBL] [Abstract][Full Text] [Related]
10. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.
Sechter D; Troy S; Paternetti S; Boyer P
Eur Psychiatry; 1999 Mar; 14(1):41-8. PubMed ID: 10572324
[TBL] [Abstract][Full Text] [Related]
11. A double-masked, placebo-controlled study of fluoxetine for hypochondriasis.
Fallon BA; Petkova E; Skritskaya N; Sanchez-Lacay A; Schneier F; Vermes D; Cheng J; Liebowitz MR
J Clin Psychopharmacol; 2008 Dec; 28(6):638-45. PubMed ID: 19011432
[TBL] [Abstract][Full Text] [Related]
12. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study.
Kuiken SD; Tytgat GN; Boeckxstaens GE
Clin Gastroenterol Hepatol; 2003 May; 1(3):219-28. PubMed ID: 15017494
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.
Corya SA; Williamson D; Sanger TM; Briggs SD; Case M; Tollefson G
Depress Anxiety; 2006; 23(6):364-72. PubMed ID: 16710853
[TBL] [Abstract][Full Text] [Related]
14. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder.
Lam RW; Levitt AJ; Levitan RD; Enns MW; Morehouse R; Michalak EE; Tam EM
Am J Psychiatry; 2006 May; 163(5):805-12. PubMed ID: 16648320
[TBL] [Abstract][Full Text] [Related]
15. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
Robinson RG; Schultz SK; Castillo C; Kopel T; Kosier JT; Newman RM; Curdue K; Petracca G; Starkstein SE
Am J Psychiatry; 2000 Mar; 157(3):351-9. PubMed ID: 10698809
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine versus placebo in posttraumatic stress disorder.
Martenyi F; Brown EB; Zhang H; Prakash A; Koke SC
J Clin Psychiatry; 2002 Mar; 63(3):199-206. PubMed ID: 11926718
[TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.
Diniz JB; Shavitt RG; Fossaluza V; Koran L; Pereira CA; Miguel EC
J Clin Psychopharmacol; 2011 Dec; 31(6):763-8. PubMed ID: 22020357
[TBL] [Abstract][Full Text] [Related]
19. Selective serotonin reuptake inhibitors for fibromyalgia syndrome.
Walitt B; Urrútia G; Nishishinya MB; Cantrell SE; Häuser W
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011735. PubMed ID: 26046493
[TBL] [Abstract][Full Text] [Related]
20. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study.
Suvanto-Luukkonen E; Koivunen R; Sundström H; Bloigu R; Karjalainen E; Häivä-Mällinen L; Tapanainen JS
Menopause; 2005; 12(1):18-26. PubMed ID: 15668596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
